Poehling Capital Management, Inc. Bausch Health Companies Inc. Transaction History

Poehling Capital Management, Inc.

$390 Million
Q3 2024

A detailed history of Poehling Capital Management, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 87,762 shares of BHC stock, worth $744,221. This represents 0.18% of its overall portfolio holdings.

Number of Shares

87,762

Previous 87,961 0.23%

Holding current value

$744,221

Previous $613,000 16.64%

% of portfolio

0.18%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $1,038 - $1,643	-199 Reduced 0.23%	87,762 $715,000
Q2 2024 Aug 08, 2024	SELL	$6.1 - $10.41 $500 - $853	-82 Reduced 0.09%	87,961 $613,000
Q1 2024 May 09, 2024	SELL	$7.77 - $10.61 $217 - $297	-28 Reduced 0.03%	88,043 $934,000
Q4 2023 Feb 13, 2024	SELL	$6.53 - $8.23 $2,598 - $3,275	-398 Reduced 0.45%	88,071 $706,000
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $538 - $679	70 Added 0.08%	88,469 $727,000
Q2 2023 Aug 14, 2023	SELL	$5.72 - $8.8 $4,295 - $6,608	-751 Reduced 0.84%	88,399 $707,000
Q4 2022 Feb 10, 2023	SELL	$6.09 - $7.93 $1,455 - $1,895	-239 Reduced 0.27%	89,150 $559,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $48,818 - $98,169	-10,659 Reduced 10.65%	89,389 $616,000
Q2 2022 Aug 09, 2022	SELL	$7.06 - $23.63 $75,930 - $254,140	-10,755 Reduced 9.71%	100,048 $836,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $238,204 - $306,468	11,028 Added 11.05%	110,803 $2.53 Million
Q4 2021 Jan 10, 2022	BUY	$23.0 - $29.01 $16,192 - $20,423	704 Added 0.71%	99,775 $2.76 Million
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $209,459 - $251,451	8,365 Added 9.22%	99,071 $2.76 Million
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $50,306 - $59,971	1,834 Added 2.06%	90,706 $2.66 Million
Q1 2021 May 11, 2021	BUY	$21.37 - $34.38 $342,988 - $551,799	16,050 Added 22.04%	88,872 $2.82 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $197,131 - $271,941	12,876 Added 21.48%	72,822 $1.52 Million
Q3 2020 Nov 10, 2020	BUY	$14.88 - $20.13 $80,768 - $109,265	5,428 Added 9.96%	59,946 $932,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $432,242 - $666,062	32,475 Added 147.33%	54,518 $997,000
Q1 2020 May 06, 2020	BUY	$12.98 - $30.25 $16,874 - $39,325	1,300 Added 6.27%	22,043 $342,000
Q4 2019 Feb 10, 2020	BUY	$18.89 - $31.89 $391,835 - $661,494	20,743 New	20,743 $621,000

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.

Account

Poehling Capital Management, Inc. Bausch Health Companies Inc. Transaction History